Exane BNP Paribas analyst Rob Jones upgraded Gecina to Outperform from Neutral with a EUR 120 price target. The analyst sees the stock as undervalued following the recent underperformance.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GECFF:
Questions or Comments about the article? Write to editor@tipranks.com